Universal Corporation

What Universal Corporation does

Universal Corporation Limited (UCL) is a Kenya-headquartered pharmaceutical manufacturer founded in 1996 by Perviz (Palu) Dhanani. It operates a single state-of-the-art, WHO-prequalified manufacturing facility in Kikuyu (established 2005), producing tablets, capsules, syrups, creams, and specialized gels across more than 100 formulations spanning anti-infectives, antivirals, antimalarials, cardiology, diabetes, dermatology, neuropsychiatry, and antiparasitic therapeutic categories. UCL is one of only two WHO-prequalified pharmaceutical manufacturers in Sub-Saharan Africa, a status first achieved in 2011 for Lamozid and extended in 2020 with Artemether-Lumefantrine certification, which enables participation in international donor-funded tenders.

The company's go-to-market operates through two parallel channels: (1) institutional procurement to UNICEF, Global Fund, USAID, Iplus, and African government health systems across 23+ countries, and (2) commercial B2B distribution through a network of 5,500+ pharmacies and 4,100+ doctors, with 4,200 of those pharmacies and 2,750 of those doctors in Kenya alone. UCL holds approvals from 11+ African regulatory authorities and exports to Pakistan, Afghanistan, Denmark, Haiti, and Yemen. Revenue derives from product sales of generic medicines, with pricing not publicly disclosed and contracts negotiated through tender and direct B2B channels. UCL has been in a strategic partnership with India's Strides since 2016, which provides embedded executive leadership for global business development (Aditya Arun Kumar) and group finance (Vikesh Kumar).

In 2024 UCL launched the UNICARE nutraceuticals division, extending the portfolio into consumer health categories (diabetes management, cardiovascular, immune support, fertility, pregnancy wellness, joint health). The company employs 500+ professionals with 50% female representation and produces over 1 billion units annually. Ownership remains concentrated under founder Perviz (Palu) Dhanani, with no disclosed venture capital, private equity, or public shareholders.

Name

Universal Corporation

Legal name

Universal Corporation Limited

Website

https://ucl.co.ke

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Universal Corporation Limited is a Kenyan WHO-prequalified pharmaceutical manufacturer producing 100+ generic formulations and nutraceuticals from its Kikuyu facility, serving governments, global health organizations, and 5,500+ pharmacies across 23+ countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Health Care and Social Assistance (62)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Maternal, Newborn, Child & Adolescent Health (MNCAH) Partnerships (HLAJAOAG)

akta.pro secondary industries

Health Systems Strengthening & Universal Health Coverage (UHC) (BPADAIAE), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Essential medicines
• Antiretroviral drugs
• Nutraceutical products

Headquarters

HQ city

Kikuyu

HQ country

Kenya

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of generic medicines across multiple therapeutic categories including antimalarials, antivirals, cardiology, diabetes, dermatology, and neuropsychiatry products to healthcare providers, pharmacies, and institutions across Africa
2. Institutional/Government Procurement: Supply of essential medicines including WHO-certified antiretrovirals to governments, global health organizations, and public health programs through procurement partnerships
3. Global Fund/USAID/UNICEF Programs: Supply of prequalified medicines to international health programs including Global Fund, USAID, and UNICEF for distribution to public health systems

Go-to-market motion2 records

Distribution channels4 records

Marketing channels2 records

Core offering

Universal Corporation Limited (UCL) is a WHO-prequalified pharmaceutical manufacturer based in Kikuyu, Kenya, producing generic medicines and nutraceuticals in the form of tablets, capsules, syrups, creams, and specialized gels. The portfolio spans anti-infectives, antivirals, antimalarials, cardiology, diabetes, dermatology, neuropsychiatry, and respiratory treatments, distributed across 23+ African countries to governments, global health organizations, pharmacies, and healthcare providers.

Product overview

Universal Corporation Ltd (UCL) is a WHO-prequalified pharmaceutical manufacturer based in Kenya, producing a diversified portfolio of generic medicines and nutraceuticals. The company operates across multiple therapeutic categories including Anti-Infectives (Univir, Flutrox), Nervous System medications (Neurotrol, Neuroba, Nervcap, Anamol), Musculo-Skeletal treatments (Anamol MR), Respiratory products (HTC, Upacof line), Alimentary Tract and Metabolism drugs (ACL Kit, Unibrol, Esmo, CHX, Magsim, Duxcospan Plus), Dermatologicals (Clotrine line, Acnesol, Rexedine, Univir Cream, Motesone, CHX Gel), Genito-Urinary and Sex Hormone products (Nelgra, Clotrine pessaries), and Antiparasitic treatments (Unigentyl, Duotab). Additionally, UCL launched the UNICARE nutraceutical division featuring products for diabetes management (Diaflor), cardiovascular health (Cardiovit), immune support (Rejuv+), perimenopausal health (Unipause), pregnancy wellness (Unipregna), fertility support (Ferti-Fem, Ferti-Mas), and musculoskeletal health (Orthopex, Orthopex-C, Unisitol). With over 100 formulations serving 23+ countries, UCL produces tablets, capsules, syrups, creams, and specialized gels from its WHO-prequalified facility in Kenya.

Differentiator

Problem solved

Functional benefit

Brands

• UNICARE: Nutraceuticals division offering products including Diaflor, Cardiovit, Rejuv+, Unipause, Unipregna, Unilacto, Ferti-Fem, Ferti-Mas, Orthopex-C, Unisitol, and Orthopex for various health conditions including diabetes, cardiovascular health, immune support, perimenopausal health, pregnancy wellness, fertility, and osteoarthritis.

Products and services

• Univir 800 Acyclovir U.S.P 800mg Tablets for treatment of initial and recurrent mucosal and cutaneous HSV-1, Varicella zoster, Chicken pox, and Cytomegalovirus.
• Univir 400 Acyclovir U.S.P 400mg Tablets for treatment of initial and recurrent mucosal and cutaneous HSV-1 and Varicella zoster.
• Flutrox 200 Fluconazole U.S.P 200mg Capsule for treatment of vaginal candidiasis, mucosal candidiasis, systemic candidiasis, cryptococcosis, and fungal skin infections.
• Neurotrol Carbamazepine 200mg Tablet for treatment of epilepsy (partial and generalized tonic-clonic seizures), trigeminal neuralgia, and bipolar disorder as a mood stabilizer.
• Neuroba Gabapentin 300mg Capsules for treatment of partial seizures and postherpetic neuralgia.
• Nervcap 150 Pregabalin 150mg Capsules for treatment of neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury, post-herpetic neuralgia, fibromyalgia, and adjunctive therapy for partial-onset seizures.
• Anamol Paracetamol 120mg/5ml Suspension for analgesic and antipyretic relief of pain and fever. WHO Essential Medicines List reference.
• Anamol MR Paracetamol 325mg + Aceclofenac 100mg + Chlorzoxazone 500mg Tablets for analgesic and antipyretic relief of pain and fever. WHO Essential Medicines List reference.
• HTC Purified honey and concentrated lemon juice syrup for treatment of dry, tickly, or scratchy coughs and sore throat.
• Upacof Expectorant Diphenhydramine-based expectorant syrup for treatment of wet coughs.
• Upacof Paediatric Diphenhydramine HCl, ammonium chloride, and sodium citrate syrup for treatment of cough, bronchial and nasal congestion, and hay fever in children.
• Upacof Dry Cough Dextromethorphan HBr syrup for treatment of hacking and dry coughs.
• ACL Kit Amoxicillin 1000mg + Clarithromycin 500mg + Lansoprazole 30mg combination pack for treatment of H.pylori infections.
• Unibrol Syrup Aminosidine U.S.P syrup for treatment of intestinal amebiasis and giardiasis.
• Esmo Esomeprazole 20mg and 40mg capsules, a proton pump inhibitor for treatment of GERD, erosive esophagitis, ulcers, and Zollinger-Ellison syndrome.
• CHX Chlorhexidine Gluconate 0.2% w/v oral solution for prevention of dental plaque, gingivitis, and oral infections.
• Magsim Magaldrate and simethicone oral suspension for relief of hyperacidity, gastritis, heartburn, and indigestion.
• Clotrine BG Clotrimazole, betamethasone, and gentamicin cream for treatment of mixed fungal and bacterial infections with redness, inflammation, and itching.
• Acnesol Tretinoin 0.05% w/w cream for treatment of acne, photodamaged skin, and hyperpigmentation.
• Univir Cream Acyclovir 5% w/w cream for treatment of initial and recurrent HSV-1 and Varicella zoster (shingles).
• Motesone Mometasone furoate 0.1% w/w cream for treatment of inflammatory and pruritic manifestations of psoriasis and atopic dermatitis.
• CHX Gel Chlorhexidine Digluconate 7.1% gel for prevention of umbilical cord infections.
• Nelgra 100 Sildenafil 100mg tablets for treatment of erectile dysfunction.
• Clotrine 200mg Pessaries Clotrimazole BP 200mg pessaries for treatment of vaginal candidiasis, vaginal trichomoniasis, mixed vaginal infection, bacterial vaginitis, and infective leucorrhea.
• Unigentyl Secnidazole 500mg tablets for treatment of intestinal amoebiasis, urogenital trichomoniasis, giardiasis, and bacterial vaginosis.
• Duotab Dihydroartemisinin 40mg and Piperaquine 320mg tablets for treatment of uncomplicated Plasmodium falciparum malaria.
• Diaflor Lactobacillus probiotic capsules with selenium and chromium for management of Type II Diabetes Mellitus.
• Cardiovit Coenzyme Q10, black pepper extract, and Berberis aristata tablets for support of coronary artery health.
• Rejuv+ Echinacea, beta glucan, curcuma longa, vitamin C, and zinc capsules for immune enhancement.
• Unipause Soy isoflavone, vitex agnus castus, calcium, magnesium, vitamin K2, and D3 tablets for perimenopausal health support.
• Unipregna Lactobacillus and Bifidobacterium probiotic capsules with inulin for pregnancy wellness support.
• Unilacto Microencapsulated Lactobacillus rhamnosus GG orosoluble sachets for treatment of diarrhoea, antibiotic-associated diarrhea, and gut dysbiosis.
• Ferti-Fem Vitex agnus castus, L-arginine, green tea extract, and vitamin/mineral combination tablets for female fertility support.
• Ferti-Mas Tribulus terrestris, co-enzyme Q10, vitamin, and mineral combination tablets for male infertility support.
• Orthopex-C Boswellia, collagen, curcuma longa, glucosamine, chondroitin, and vitamin combination tablets for moderate to severe osteoarthritis.
• Unisitol Myo inositol, D chiro inositol, chromium, vitamin D3, folic acid, and zinc tablets for Polycystic Ovarian Syndrome support.
• Orthopex Native collagen type II, rosehip extract, and collagen peptide sachets for mild to moderate osteoarthritis.
• UNICEF Co-Pack (ORS with Zinc) Co-Pack combining ORS (Oral Rehydration Salts) with zinc for treating childhood diarrhea across Africa in collaboration with UNICEF.

Quantifiable outcome

• Reached 23+ countries with approvals from 11+ African regulatory authorities
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core.

• StridescoreStrategic or Co-development Partner · 1 January 2016Strategic partnership since 2016 with Strides (global pharmaceutical company) strengthening global presence and capabilities. Aditya Arun Kumar serves as Executive Director from Strides, leading global partnered business. Partnership enables technology transfer and market expansion.
• UNICEFcoreStrategic or Co-development Partner · 1 January 2010Partnership since 2010 for development of Co-Pack (ORS with zinc) for treating childhood diarrhea and CHX gel for umbilical cord care. UNICEF collaboration improving child health outcomes across the African continent through essential health products.
• Global FundcoreChannel Partner/ Reseller/ DistributorSupply of WHO-prequalified essential medicines to Global Fund programs for distribution to public health systems across Africa
• USAIDcoreChannel Partner/ Reseller/ DistributorSupply of essential medicines to USAID international health programs supporting developing country health systems
• IpluscoreChannel Partner/ Reseller/ DistributorDistribution partner supporting supply chain and distribution operations across Africa

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Strides Pharma Science: Indian generic pharmaceutical manufacturer with WHO-prequalified facilities supplying global health programs; UCL's strategic partner since 2016. Directly comparable product portfolio (ARVs, antimalarials) and overlapping institutional customer base (Global Fund, USAID).
• Ajanta Pharma: Indian generic manufacturer with strong African branded-generics footprint across 30+ countries. Comparable therapeutic areas (anti-infectives, dermatology, cardiology) and similar business model of supplying African pharmacy networks and government tenders.
• Aurobindo Pharma: Large Indian generic manufacturer with significant WHO-prequalified ARV and anti-malarial production supplying global health programs. Direct competitor on Global Fund/USAID tenders and increasingly a price benchmark in African institutional procurement.
• Emcure Pharmaceuticals: Indian pharmaceutical company with WHO-prequalified manufacturing and emerging African commercial footprint. Competes in the same institutional and generic-pharmacy channels with overlapping therapeutic categories.
• Lupin Pharmaceuticals: Indian generic manufacturer with WHO-prequalified facilities and growing African market presence. Overlaps with UCL in anti-infectives, CNS, and dermatology segments and competes for the same African institutional tenders.
• Aspen Pharmacare: South Africa's largest pharmaceutical manufacturer producing generics, ARVs, and consumer health products across Africa and emerging markets. Comparable as a Sub-Saharan African generic manufacturer serving both institutional donors and commercial pharmacy channels.
• Cipla: Major Indian generic manufacturer with significant African presence and WHO-prequalified ARV/antimalarial production. Competes head-to-head with UCL for Global Fund and African government tenders across the same therapeutic categories.

Broad incumbents

• Sanofi: Global pharmaceutical company with established African commercial operations across generics, vaccines, and specialty care. Overlaps with UCL in anti-infectives and chronic disease treatments via institutional and pharmacy channels.
• GlaxoSmithKline (GSK): Global pharmaceutical major with broad African presence including vaccines, ARVs, and consumer health. Competes with UCL on the same essential-medicines tenders but at much larger scale and with branded rather than generic positioning.

Regional players

• Adcock Ingram: South African pharmaceutical manufacturer distributing prescription, generic, and OTC products across Sub-Saharan Africa. Comparable in therapeutic breadth and African regulatory footprint but primarily South African-anchored.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/universal_kenya
• LinkedInlinkedin.com/company/universal-corporation-ltd-

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Universal Corporation